Moody’s downgrades Senegal to Caa1 amid rising debt concerns
Friday’s trading session is witnessing significant movements across stocks of various market caps, with particular attention on the mega-cap and large-cap categories. Mizuho’s downgrade of Venture Global Inc (VG) and the surge in AltC Acquisition (OKLO) are among the headlines influencing the market today. Here are some of the most notable stock movers, reflecting the dynamic nature of today’s market.
Mega-Cap Movers:
- Venture Global Inc (VG); Mizuho downgrades Venture Global stock on arbitration setback: -19.52%
Large-Cap Stock Movers:
- AltC Acquisition (OKLO): +10.39%
- Vector Acquisition (RKLB); Rocket Lab secures two dedicated launches for JAXA’s satellite program: +6.75%
- GS Acquisition A (VRT): +5.91%
- Iris Energy (IREN): +5.05%
- Mosaic Company (MOS); Mosaic stock rating downgraded by RBC Capital on phosphate production cuts: -7.58%
- Yum China Holdings Inc (YUMC): +4.88%
- Coherent (COHR): +4.87%
- Network Appliance Inc (NTAP): -3.7%
- Fermi America LLC (FRMI): +3.85%
Mid-Cap Stock Movers:
- Applied Blockchain (APLD): +26.39%
- Cryptyde (ORBS); Eightco launches AI authentication pilot program for enterprises: +23.7%
- Diginex Inc (DGNX): -20.36%
- Corcept Therapeutics (CORT): -12.69%
- Kensington Capital Acquisition (QS): +8.94%
- GigCapital4 (BBAI): +14.69%
- Uranium Energy Corp (UEC): +12.15%
- Levi Strauss & Co (LEVI): -10.57%
- Ikonics Corp (WULF): +10.34%
- Good Works Acquisition (CIFR): +8.48%
Small-Cap Stock Movers:
- USANA Health Sciences Inc (USNA); USANA reports preliminary Q3 results below expectations: -22.04%
- OKLL (OKLL): +21.88%
- ASP Isotopes (ASPI): +21.75%
- Targacept (GYRE); Jefferies initiates Gyre Therapeutics stock with Buy rating, $16 target: +17.2%
- Summit Semiconductor (DVLT): -18.2%
- Decarbonization Plus Acq (SLDP): +14.76%
- Allogene Therapeutics Inc (ALLO); Allogene stock downgraded by JPMorgan on concerns over program changes: -12.25%
- WhiteFiber (WYFI): +10.81%
- OrthoPediatrics (KIDS); OrthoPediatrics lowers 2025 revenue guidance after Q3 headwinds: -13.37%
- Churchill Capital (CCCX): +11.84%
For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.